Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nazanin Ijad
Observed names:
Ijad, Nazanin,
N Ijad
Institutions:
Massachusetts General Hospital,
Center for Cancer Research
Observed institutions:
University Health Network,
Harvard University,
University of Toronto,
Princess Margaret Cancer Centre,
Massachusetts General Hospital,
Center for Cancer Research,
Mass General Brigham
show all 7
OpenAlex ID:
A5081881863
Loss of H3K27me3 in meningiomas
2021
·
Farshad Nassiri
, Justin Z Wang
, et al.
·
Neuro-Oncology
·
78
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results
2023
·
Priscilla K. Brastianos
, Albert E. Kim
, et al.
·
Nature Medicine
·
66
PDF
Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities
2023
·
Suganth Suppiah
, Sheila Mansouri
, et al.
·
Nature Communications
·
49
PDF
Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysis
2020
·
Farshad Nassiri
, Shervin Taslimi
, et al.
·
Clinical Cancer Research
·
25
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells
2025
·
Rishab Ramapriyan
, Fred G Barker
, et al.
·
Neuro-Oncology
·
6
Combination therapy of adagrasib and abemaciclib in non-small cell lung cancer brain metastasis models genomically characterized by KRAS-G12C and homozygous loss of CDKN2A
2025
·
Christian Migliarese
, Yinon Sadeh
, et al.
·
Acta Neuropathologica Communications
·
6
PDF
Novel Systemic Approaches for the Management of Meningiomas
2023
·
Nazanin Ijad
, Ashish Dahal
, et al.
·
Neurosurgery Clinics of North America
·
5
Clinical value of methylation testing: a case report of intraventricular schwannomas with associated molecular findings
2020
·
Justin Z Wang
, Neda Pirouzmand
, et al.
·
Neuro-Oncology Advances
·
4
PDF
Ctim-02. Phase 2 Trial of Pembrolizumab for Patients With Brain Metastases of Diverse Histologies
2023
·
Priscilla Brastianos
, Albert Kim
, et al.
·
Neuro-Oncology
·
1
PDF
Exth-89. Exploring Anti-tumor Effects of Small Molecule Inhibitors of Cdk4/6, Fak, and Raf/mek in Preclinical Models of Meningioma
2022
·
Nazanin Ijad
, Katie L Waller
, et al.
·
Neuro-Oncology
·
1
PDF
Combining the KRASG12C inhibitor adagrasib with anti-PD-1 immunotherapy improves overall survival and prevents recurrence in preclinical models of brain metastasis
2026
·
Consuelo Torrini
, Naema Nayyar
, et al.
·
Neuro-Oncology Advances
Combination treatment with RAF/MEK inhibitor avutometinib and FAK inhibitor defactinib in preclinical models of meningioma
2026
·
Nazanin Ijad
, Katie L Waller
, et al.
·
Neuro-Oncology Advances
EXTH-47. Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells
2025
·
Rishab Ramapriyan
, Fred Barker 2nd
, et al.
·
Neuro-Oncology
PDF
DDDR-71. Dual inhibition of RAF/MEK and FAK signaling improves survival in intracranial meningioma models
2025
·
Nazanin Ijad
, Katie L Waller
, et al.
·
Neuro-Oncology
PDF
Exth-41. Combination Treatment With Raf/mek and Fak Inhibition Enhances Tumor Growth Inhibition in Meningioma
2024
·
Nazanin Ijad
, Katie L Waller
, et al.
·
Neuro-Oncology
PDF
Dddr-04. Preclinical Investigation of a Novel Brain Penetrant Combination Therapy Targeting Raf and Mek for Melanoma Brain Metastasis
2024
·
Erika Yamazawa
, Naema Nayyar
, et al.
·
Neuro-Oncology
PDF
Dddr-32. Evaluating the Therapeutic Effects of Small Molecule Inhibitors of Cdk4/6 and Fak in Preclinical Meningioma Models
2023
·
Nazanin Ijad
, Katie Waller
, et al.
·
Neuro-Oncology
PDF
Exth-45. Development of Combination Therapies of Krasg12c Inhibitor Adagrasib in Preclinical Models of Brain Metastasis
2023
·
Consuelo Torrini
, Christian Migliarese
, et al.
·
Neuro-Oncology
PDF
Exth-42. Preclinical Investigation of a Novel Brain Penetrant Mek Inhibitor to Target Brain Metastasis
2023
·
Erika Yamazawa
, Naema Nayyar
, et al.
·
Neuro-Oncology
PDF
Supplementary Data from Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysis
2023
·
Farshad Nassiri
, Shervin Taslimi
, et al.
Supplementary Data from Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysis
2023
·
Farshad Nassiri
, Shervin Taslimi
, et al.
PDF
Data from Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysis
2023
·
Farshad Nassiri
, Shervin Taslimi
, et al.
Data from Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysis
2023
·
Farshad Nassiri
, Shervin Taslimi
, et al.
Abstract 4181: CDK4/6 inhibition with Abemaciclib improves intracranial and extracranial response to checkpoint blockade in pre-clinical models of brain metastasis
2022
·
Naema Nayyar
, Mohini Singh
, et al.
·
Cancer Research
P.091 Surgical outcomes for patients undergoing repeat endoscopic endonasal trans-sphenoidal surgery for recurrent pituitary adenomas
2019
·
E Toyota
, J Wang
, et al.
·
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
PDF
Show more works
View as search
Works count:
27
Citation count:
241
H-index:
6
I10-index:
4
Year
Topic
Type